Skip to content
Dose Brief
Menu
No. 1 on the board · Grade APartner

CoreAge Rx review

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Visit CoreAge Rx Partner — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$149/mo
Tirzepatide
$349/mo
Coverage
All 50 states
Brand-name
Compounded only
On the trackerStableprice stableFlat rate held for a third straight cycle — no first-month teaser to reset.

The scorecard

CoreAge Rx scored on our six Brief Score factors. See the methodology.

Price Stability97/100
Supply Reliability95/100
Transparency90/100
Access Breadth93/100
Clinical Oversight92/100
Track Record88/100

What we like

  • Flat monthly price with no intro-rate step-up after month one — the most stable line on our tracker
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states — the widest reliable footprint in the partner tier
  • Low-friction cancellation, so you're never locked in

The caveats

  • Not the rock-bottom price — cheaper teaser tiers exist, but they don't hold
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

The brief

Best for: Readers who want a price they can plan around — no teaser-rate reset, no surprise membership fee, both molecules on one account. The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Ranked #1 of 9 providers we reviewed — see our #2 pick, Eden, for comparison.

Compare with other providers

All 8 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect CoreAge Rx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on CoreAge Rx's site. Not medical advice; see our disclosure.

← Back to all rankings